The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature reviewBao‐Dong Qin, Yuan‐Sheng Zang, Lingyan Yuan et al.|OncoTargets and Therapy|2018Cited by 33